LeMaitre Vascular reported a productive Q4 2024 with sales up 14%, operating income up 26%, and EPS up 30%. The company also announced an increased quarterly dividend and authorized a share repurchase program.
Sales increased 14% to $55.7 million in Q4 2024, driven by strong organic growth.
Operating income grew 26% to $12.9 million, with an operating margin of 23%.
Diluted earnings per share rose 30% to $0.49.
The company's cash balance increased sequentially to $299.7 million, providing strategic optionality.
LeMaitre Vascular provided Q1 2025 and Full Year 2025 guidance, projecting continued growth in sales, operating income, and EPS.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance